Skip to main content
Don't miss
Hallway Huddle
- Chronic kidney disease in type 2 diabetes
Check Out: KLINRISK: Clinical Risk Prediction for Kidney Disease
Home
Presentations
YouTubule
Resources
eGFR Calculator
Calculators
Search
Contact Us
Welcome
Presentations
YouTubule
Resources
Calculators
Hyperkalemia Channel
Hyperkalemia Channel Home
Sodium zirconium cyclosilicate (SZC)
Hot Topics in Hyperkalemia
Hyperkalemia Hot Topics
Hyperkalemia Hot Topics 2
Re-establishing normokalemia in patients on hemodialysis
Chronic hyperkalemia optimization tool
Patiromer Mechanism of Action
Ask the Experts
Bone & Mineral Metabolism Resource
eGFR Calculator
Kidney Failure Risk Equation (KFRE)
Nephrology Nutrition
Images in Nephrology
Nephrology Articles
Nephrology Polls
Renal Pathology
Toxicology
Toxicology posts by agent
Toxicology primer
Publications
Nephrology manuals
Dialysis Vascular Access
Patient Training for Peritoneal Dialysis
Guidelines
Peritoneal Dialysis
News
Nephrology News Tracker
Nephrology Developments
Network
Search
Home
Resources
Nephrology Articles
Fluid and Electrolytes
Potassium
Hyperkalemia
Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors
Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors
Weir MR, Bakris GL, Bushinsky DA, Mayo MR, Garza D, Stasiv Y, Wittes J, Christ-Schmidt H, Berman L, Pitt B; OPAL-HK Investigators
N Engl J Med. 2015 Jan 15;372(3):211-21
Categories:
Hyperkalemia
Potassium
Fluid and Electrolytes
Tags:
Randomized Trial
Specifications
Journal Link
Pubmed
Free PDF
229
ukidneyisup